Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Psychiatry|November 24, 2004
Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled studyVladimir Lerner, Joseph Bergman, Nikolay Statsenko, et al.
Clinical Neuropharmacology|January 6, 2011
Efficacy of bupropion XR in treatment-resistant elderly patients: a case series studyJoseph Bergman, Chanoch Miodownik, Alex Palatnik, et al.
Clinical Neuropharmacology|April 3, 2003
Donepezil as add-on treatment of psychotic symptoms in patients with dementia of the Alzheimer's typeJoseph Bergman, Izidor Brettholz, Michael Shneidman, et al.
The Australian and New Zealand Journal of Psychiatry|September 7, 2010
Shared obsessive-compulsive disorder: broadening the concept of shared psychotic disorderJoseph Mergui, Sol Jaworowski, David Greenberg, et al.
Clinical Neuropharmacology|December 13, 2005
Lithium intoxication associated with intramuscular ziprasidone in schizoaffective patientsChanoch Miodownik, Michael Hausmann, Katherina Frolova, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 23, 2003
Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorderVladimir Lerner, Igor Libov, Moshe Kotler, et al.
CNS Drugs|March 13, 2016
Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to DateVladimir Lerner, Peter J A McCaffery, Michael S Ritsner
The Journal of Clinical Psychiatry|September 13, 2006
The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled studyChanoch Miodownik, Vladimir Lerner, Adi Kibari, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover studyIgor Libov, Chanoch Miodownik, Yuly Bersudsky, et al.
Clinical Neuropharmacology|March 30, 2005
Augmentation with amisulpride for schizophrenic patients nonresponsive to antipsychotic monotherapyVladimir Lerner, Joseph Bergman, Alexander Borokhov, et al.
Pageof 10